Intrinsiqs

Is Cytokinetics, Incorporated overvalued?

Cytokinetics, Incorporated (CYTK) — key valuation metrics and fundamentals.

No verdict
Price
$86.26
Fair value
Current P/E
Normal P/E
Market cap
$10.60B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares CYTK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.